2001
Former HCFA Administrator and Current Eli Lilly and Company Executive Vice President Added to the Board Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) announced that Guidant's...
Emerging Therapies Position Company for Future Success Indianapolis, Ind. - Ronald W. Dollens, president and CEO of Guidant Corporation (NYSE and PCX: GDT), today provided a positive forecast of...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular therapy technology, today announced that it will host a live webcast of its briefing at the...
Company's Second Non-Coronary Stent System Approved Within the Past Month Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Company Receives FDA Approval of MULTI-LINK PENTA Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease,...
>Guidant Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that it will...
Indianapolis, IN and St. Paul, MN - Late this afternoon, various news organizations quoted a U.S. Food and Drug Administration (FDA) spokesperson who commented on Guidant's May 2 release...
PRIZM AVT Pulse Generator Receives European CE Mark Approval Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today...
System Combines Sensor and Diagnostic Capabilities to Enhance Therapy Delivery Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular...
Guidant's System Designed to Treat Heart Failure and Prevent Sudden Cardiac Death. Trial Results Suggest a Slowing of Heart Failure Progression, Improvements in Functional Capacity and Quality of...